FDA Panel To Review Pfizer Vaccine For Children

The video discusses an FDA panel meeting to review Pfizer's COVID-19 vaccine for children aged 5 to 11, highlighting its 90% efficacy against symptomatic disease. The process involves FDA recommendations, followed by CDC guidance. The White House plans to distribute vaccines through pediatricians, hospitals, and schools. Despite most parents willing to vaccinate their children, some hesitancy remains, with polls indicating that mandates or full FDA approval could influence decisions.

What age group is Pfizer's COVID vaccine being considered for by the FDA panel?

• 16 to 18 years

• 12 to 15 years

• 5 to 11 years

• 2 to 4 years

What is the next step after the FDA panel makes its recommendations?

• CDC issues its guidance

• FDA issues an emergency use authorization

• Manufacturers begin shipping doses

• Vaccines are administered immediately

How many doses is the White House prepared to ship in the first week after authorization?

• 5 million

• 10 million

• 15 million

• 20 million

Which of the following is NOT part of the White House's plan for vaccine distribution?

• Collaborating with community health centers

• Partnering with international health organizations

• Setting up clinics at local schools

• Working with pediatricians

What percentage of parents said a school vaccine mandate would persuade them to vaccinate their children?

• 45%

• 35%

• 25%

• 15%